#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17418	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2581	833.5	0	.	n	.	0	A69G	SNP	69	69	A	482	482	G	1060	G	1060	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17418	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2581	833.5	0	.	n	.	0	C450T	SNP	450	450	C	863	863	T	1167	T,G,C,A	1163,2,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17418	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2581	833.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1863	1863	T	1128	T,G,C,A	1122,3,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17418	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2581	833.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1597	1597	C	1138	C	1138	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30002	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4055	922.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1936	1936	A	1263	A	1261	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30002	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4055	922.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2570	2570	C	979	C,T	978,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30002	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4055	922.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2644	2644	A	893	A,C	892,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30002	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4055	922.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3196	3196	C	1077	C,T	1074,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2600	folP	852	852	99.88	folP.l15.c4.ctg.1	1995	162.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	978	980	AAA	244;239;235	A;A,G;A,C	244;238,1;234,1	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2600	folP	852	852	99.88	folP.l15.c4.ctg.1	1995	162.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1209	1211	AGC	258;258;263	A,C;G;C	257,1;258;263	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6514	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3770	215.3	1	SNP	p	S91F	0	.	.	271	273	TCC	717	719	TCC	247;245;244	T;C;C	247;245;244	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6514	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3770	215.3	1	SNP	p	D95G	0	.	.	283	285	GAC	729	731	GAC	245;246;248	G,T;A;C	244,1;246;248	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6514	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3770	215.3	1	SNP	p	D95N	0	.	.	283	285	GAC	729	731	GAC	245;246;248	G,T;A;C	244,1;246;248	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2494	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1846	168.4	1	SNP	p	G45D	0	.	.	133	135	GGC	725	727	GGC	285;287;291	G;G;C	285;287;291	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1450	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1363	132.4	0	.	n	.	0	A197.	DEL	197	197	A	743	743	A	296	A,C	295,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5770	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3435	209.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1851	1853	GCA	244;242;243	G;C;A	244;242;243	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5770	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3435	209.4	1	SNP	p	D86N	0	.	.	256	258	GAC	804	806	GAC	287;286;285	G,A;A;C	286,1;286;285	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5770	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3435	209.4	1	SNP	p	S87W	0	.	.	259	261	AGT	807	809	AGT	288;291;293	A;G;T	288;291;293	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5770	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3435	209.4	1	SNP	p	S87I	0	.	.	259	261	AGT	807	809	AGT	288;291;293	A;G;T	288;291;293	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5770	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3435	209.4	1	SNP	p	S87R	0	.	.	259	261	AGT	807	809	AGT	288;291;293	A;G;T	288;291;293	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5770	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3435	209.4	1	SNP	p	S88P	0	.	.	262	264	TCC	810	812	TCC	293;291;293	T;C,G;C,G	293;290,1;292,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5428	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3234	209.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1808	1810	GGC	290;288;284	G;G;C	290;288;284	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	A502V	1	A502V	NONSYN	1504	1506	GCG	2051	2053	GTG	261;256;253	G,T;T,G,C;G	260,1;253,2,1;253	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1478	1480	GCA	264;265;267	G;C,A;A	264;264,1;267	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1481	1483	ATC	271;270;273	A;T;C,T,A	271;270;271,1,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1493	1495	GTG	287;288;288	G,T;T,G;G,T	286,1;286,2;287,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1493	1495	GTG	287;288;288	G,T;T,G;G,T	286,1;286,2;287,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1997	1999	ACC	280;279;280	A;C;C	280;279;280	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2174	2176	GGC	272;272;271	G;G,T,A;C	272;270,1,1;271	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2183	2185	GGC	267;265;267	G,T;G,C;C	266,1;264,1;267	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4932	penA	1749	1749	99.94	penA.l6.c17.ctg.1	2842	216.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2201	2203	CTG	275;277;278	C,G;T,A;G,T	274,1;276,1;277,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6950	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3555	243.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1862	1864	CCG	319;318;318	C,A;C,T,A;G,A,C	317,1;316,1,1;316,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3070	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2147	178.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	680	680	C	213	C	213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	0	.	p	.	0	V37_E38insAYRSV	INS	109	109	G	677	677	G	302	G	302	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	0	.	p	.	0	G46S	NONSYN	136	138	GGC	719	721	AGC	317;319;321	A;G;C	317;319;321	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	0	.	p	.	0	V98I	NONSYN	292	294	GTC	875	877	ATC	273;276;279	A,G;T;C,T	272,1;276;278,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	0	.	p	.	0	R143K	NONSYN	427	429	AGA	1010	1012	AAA	294;295;298	A;A;A,T	294;295;297,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1214	1214	T	295	T,A	294,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	1	SNP	p	A121N	0	.	.	361	363	GCC	944	946	GCC	264;265;270	G;C;C,A	264;265;269,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3558	porB1b	1035	1035	96.52	porB1b.l15.c4.ctg.1	2023	219.1	1	SNP	p	A121D	0	.	.	361	363	GCC	944	946	GCC	264;265;270	G;C;C,A	264;265;269,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12068	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5376	279.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2235	2237	CAT	326;326;325	C,T,A;A;T,G,C	324,1,1;326;323,1,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1740	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1350	160.5	1	SNP	p	V57M	1	.	.	169	171	ATG	673	675	ATG	327;330;329	A;T;G	327;330;329	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
